Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas
14 Visninger
• 07/18/23
0
0
Indlejre
administrator
Abonnenter
Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer